Yanbing Li
Clinical trials sponsored by Yanbing Li, explained in plain language.
-
New diabetes drug tested against standard treatment in major Real-World trial
Disease control Not yet recruitingThis study aims to compare the effectiveness and safety of two diabetes medications, cofrogliptin and linagliptin, when added to insulin therapy. It will follow nearly 600 Chinese adults with type 2 diabetes whose blood sugar isn't well controlled on their current treatment. The …
Sponsor: Yanbing Li • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Diabetes breakthrough? study tests new ways to keep blood sugar controlled after intensive treatment
Disease control Not yet recruitingThis study aims to find the best long-term treatment for people with type 2 diabetes whose blood sugar isn't well controlled on pills alone, even after they receive a short, intensive course of insulin therapy. Researchers will compare three different medication combinations to s…
Phase: PHASE4 • Sponsor: Yanbing Li • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC